STOCK TITAN

Evolv Technologies (EVLV) director exercises options and sells 80,745 shares

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Michael Ellenbogen, a director of Evolv Technologies Holdings, Inc., exercised stock options for 80,745 shares of Class A Common Stock at $0.24 per share and on the same date sold 80,745 shares at a weighted-average price of $5.94 under a Rule 10b5-1 trading plan. Following these transactions, he holds 2,083,961 shares directly, 151,135 shares indirectly through the Family Horizon Trust, and 897,014 stock options expiring on September 13, 2027.

Positive

  • None.

Negative

  • None.
Insider Ellenbogen Michael
Role Director
Sold 80,745 shs ($480K)
Type Security Shares Price Value
Exercise Stock Option (Right to Buy) 80,745 $0.00 --
Exercise Class A Common Stock 80,745 $0.24 $19K
Sale Class A Common Stock 80,745 $5.94 $480K
holding Class A Common Stock -- -- --
Holdings After Transaction: Stock Option (Right to Buy) — 897,014 shares (Direct); Class A Common Stock — 2,164,706 shares (Direct); Class A Common Stock — 151,135 shares (Indirect, Held by Family Horizon Trust)
Footnotes (1)
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
Shares sold 80,745 shares Class A Common Stock sold on 2026-07-15
Sale price $5.94 per share Weighted-average price for 80,745 shares sold
Options exercised 80,745 shares Class A Common Stock acquired via option exercise on 2026-07-15
Option exercise price $0.24 per share Exercise price for stock options converted into 80,745 shares
Direct holdings after transactions 2,083,961 shares Direct Class A Common Stock owned following the sale
Indirect holdings (trust) 151,135 shares Class A Common Stock held via Family Horizon Trust
Remaining stock options 897,014 options Stock Option (Right to Buy) outstanding after the exercise; expire 2027-09-13
Rule 10b5-1 trading plan regulatory
"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
underlying security financial
"underlying_security_title: Class A Common Stock"
Family Horizon Trust financial
"nature_of_ownership: Held by Family Horizon Trust"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Michael Ellenbogen report for EVLV on July 15, 2026?

On July 15, 2026, Michael Ellenbogen exercised options for 80,745 EVLV Class A shares at $0.24 and sold 80,745 shares at a weighted-average price of $5.94. The sale was executed under a Rule 10b5-1 trading plan.

How many Evolv Technologies (EVLV) shares did Michael Ellenbogen sell and at what price?

Michael Ellenbogen sold 80,745 shares of EVLV Class A Common Stock at a weighted-average price of $5.94 per share. The shares were sold in multiple transactions under a pre-arranged Rule 10b5-1 trading plan entered on June 12, 2025.

What options did Michael Ellenbogen exercise in this EVLV Form 4 filing?

He exercised 80,745 stock options for EVLV Class A Common Stock at an exercise price of $0.24 per share. The option vested 25% on January 31, 2018 and then in 36 equal monthly installments, and the remaining options expire on September 13, 2027.

What are Michael Ellenbogen’s direct and indirect EVLV share holdings after these transactions?

After the reported transactions, Michael Ellenbogen directly holds 2,083,961 shares of EVLV Class A Common Stock and indirectly holds 151,135 shares through the Family Horizon Trust. He also has 897,014 stock options outstanding following the option exercise.

Were the EVLV share sales by Michael Ellenbogen under a Rule 10b5-1 plan?

Yes. The Form 4 states the sales were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. This indicates the transactions followed a pre-arranged plan rather than discretionary, real-time trading decisions.

How many EVLV stock options remain outstanding for Michael Ellenbogen after this exercise?

Following the exercise of 80,745 options, Michael Ellenbogen has 897,014 stock options remaining. These options relate to EVLV Class A Common Stock and carry an exercise price of $0.24 per share, with an expiration date of September 13, 2027.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ellenbogen Michael

(Last)(First)(Middle)
C/O EVOLV TECHNOLOGIES, INC.
500 TOTTEN POND ROAD, 4TH FLOOR

(Street)
WALTHAM MASSACHUSETTS 02451

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Evolv Technologies Holdings, Inc. [ EVLV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock07/15/2026M80,745A$0.242,164,706D
Class A Common Stock07/15/2026S80,745(1)D$5.94(2)2,083,961D
Class A Common Stock151,135IHeld by Family Horizon Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$0.2407/15/2026M80,745 (3)09/13/2027Class A Common Stock80,745$0897,014D
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3. The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
Remarks:
/s/ Rachel Roy, Attorney-in-fact for Michael Ellenbogen07/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)